EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis

Xiahao Ding, Li Yin, Lin Zhang, Yang Zhang, Tianming Zha, Wen Zhang, Bo Gui iD, Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & Dementia · 2024-07 · 20 (7) · 4583-4593

DOI: 10.1002/alz.13882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.06.2024. Verfasst von Xiahao Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Alzheimer Disease, Disease Progression. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, DOD ADNI (Department of Defense).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Mild cognitive impairment (MCI) heightens Alzheimer's disease (AD) risk, with diabetes mellitus (DM) potentially exacerbating this vulnerability. This study identifies the optimal intervention period and neurobiological targets in MCI to AD progression using the Alzheimer's Disease Neuroimaging Initiative dataset. METHODS Analysis of 980 MCI patients, categorized by DM status, used propensity score matching and inverse probability treatment weighting to assess rate of conversion from MCI to AD, neuroimaging, and cognitive changes. RESULTS DM significantly correlates with cognitive decline and an increased risk of progressing to AD, especially within the first year of MCI follow‐up. It adversely affects specific brain structures, notably accelerating nucleus accumbens atrophy, decreasing gray matter volume and sulcal depth. DISCUSSION Findings suggest the first year after MCI diagnosis as the critical window for intervention. DM accelerates MCI‐to‐AD progression, targeting specific brain areas, underscoring the need for early therapeutic intervention. Highlights Diabetes mellitus (DM) accelerates mild cognitive impairment (MCI)‐to‐Alzheimer's disease (AD) progression within the first year after MCI diagnosis. DM leads to sharper cognitive decline within 12 months of follow‐up. There is notable nucleus accumbens atrophy observed in MCI patients with DM. DM causes significant reductions in gray matter volume and sulcal depth. There are stronger correlations between cognitive decline and brain changes due to DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAlzheimer DiseaseDisease ProgressionHumansMaleFemaleAgedNeuroimagingBrainMagnetic Resonance ImagingAtrophyDiabetes MellitusAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseasediabetes mellitusmild cognitive impairmentnucleus accumbens

Autor:innen und Institutionen

  • Department of Anesthesiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Medical Imaging Center, the Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
  • Institute of Medical Imaging and Artificial Intelligence, Nanjing University, Nanjing, China.

ORCID-Profile: Bo Gui

Förderung

  • NIA NIH HHS
  • DOD ADNI (Department of Defense)

Zitieren

APA

Ding, X., Yin, L., Zhang, L., Zhang, Y., Zha, T., Zhang, W., Gui, B., & Alzheimer's Disease Neuroimaging Initiative (2024). Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis. Alzheimer's & Dementia, 20(7), 4583-4593. https://doi.org/10.1002/alz.13882

Vancouver

Ding X, Yin L, Zhang L, Zhang Y, Zha T, Zhang W, et al. Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis. Alzheimer's & Dementia. 2024;20(7):4583-4593. doi:10.1002/alz.13882

BibTeX
@article{Ding2024,
  author = {Ding, Xiahao and Yin, Li and Zhang, Lin and Zhang, Yang and Zha, Tianming and Zhang, Wen and Gui, Bo and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
  title = {Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {7},
  pages = {4583--4593},
  doi = {10.1002/alz.13882}
}
Kostenlos starten →